Sebela Women's Health Inc.
Clinical trials sponsored by Sebela Women's Health Inc., explained in plain language.
-
New IUD shows promise for 3-Year pregnancy prevention
Disease control CompletedThis study tested a new intrauterine device (IUD) called LevoCept, which releases a hormone to prevent pregnancy for up to 3 years. Researchers enrolled 279 women aged 18-40 to see how well it works, how safe it is, and how easy it is to place. The goal was to gather data needed …
Phase: PHASE2 • Sponsor: Sebela Women's Health Inc. • Aim: Disease control
Last updated May 09, 2026 05:35 UTC
-
New copper IUD shows promise for Long-Term contraception
Disease control CompletedThis study tested a new copper intrauterine device (IUD) called VeraCept for long-acting birth control. It involved 286 women aged 18-40 and measured how well it prevents pregnancy, how easy it is to insert, and any side effects. The goal was to gather data to plan a larger Phase…
Phase: PHASE2 • Sponsor: Sebela Women's Health Inc. • Aim: Disease control
Last updated May 06, 2026 16:15 UTC